NL-OMON21835已完成不适用
Efficacy of Carboplatin Administered Concomitantly With Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients, A Groupwide Phase III Study.
International: Children's Oncology Group (COG)Netherlands: Dutch Childhood Oncology Group (DCOG)Childhood Oncology Group (COG)COG Operations Center440 E. Huntington Drive, 4th FloorArcadia, CA 91006-3776USATel: (626) 447-00640 个研究点目标入组 8 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 8
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age greater than or equal to 3 and less than 22 years at the time of diagnosis;
- •2. Newly diagnosed, previously untreated: (1) M0 Medulloblastoma with >1.5 cm2 residual; (2) M+ Medulloblastoma; (3) M0 or M+ Supratentorial PNET (including pineoblastoma). Patients with diffusely anaplastic medulloblastoma are eligible regardless of M-stage or residual tumor. All patients with M4 disease are not eligible;
排除标准
- •See general (inclusion) criteria.
研究者
相似试验
未知
2 期
Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primaryCancer of unknown primaryJPRN-UMIN000001236ational Cancer Center Hospital, Tokyo35
已完成
不适用
Study of carboplatin based combination chemotherapy for good prognosis metastatic malignant teratomaCancerTesticular cancerISRCTN69711558Medical Research Council (MRC) (UK)450
已完成
2 期
A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted TherapiesNSCLC Stage IIIBNSCLC Stage IVEGFR Gene MutationALK Gene Rearrangement PositiveROS1 Gene MutationNCT04042558Centre Francois Baclesse150
招募中
1 期
A phase I/II study of carboplatin in combination with nab-paclitaxel and thoracic radiation in elderly patients with previously untreated non-small cell lung cancerocally Advanced Non-Small Cell Lung CancerJPRN-UMIN000016730Foundation for Biomedical Research and Innovation43
招募中
2 期
Phase II study of Carboplatin and alternate-day administrations of TS-1 in patients with advanced squamous cell lung cancer.Squamous cell carcinoma of the lungJPRN-UMIN000009308Kyoto Thoracic Oncology Research Group35